Clinical trial
Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT00247117 · Kaplan Medical Center, Other · Unknown status
Key facts
| NCT number | NCT00247117 |
|---|---|
| Title | Metformin in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Official title | Study of the Effect of Metformin in Patients With Non-Alcoholic Fatty Liver Disease |
| Lead sponsor | Kaplan Medical Center, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Liver Diseases |
| Intervention type | Drug |
| Interventions | Metformin |
| Enrollment | 15 |
| Start date | Jan 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Nov 1, 2005 |
| Last update posted | Oct 9, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: